Loading
Chan AW, Lin H, Yacoub I, et al. Proton Therapy in Uveal Melanoma. Cancers. 2024; 16(20):3497. https://doi.org/10.3390/cancers16203497
Marinkovic M, Pors LJ, van den Berg V, et al. Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy. Cancers (Basel). 2021;13(24):6241. Published 2021 Dec 13. doi:10.3390/cancers13246241
J. Thariat, J. Salleron, C. Maschi, et. al. Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas. Radiat Oncol. 2019 Dec 27; 14: 239.
Scholz SL, Hérault J, et. al. Proton radiotherapy in advanced malignant melanoma of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 2019 Mar 27.
C. Jiang, T. Hoover, M.M. Kim, et al. Outcomes of Proton Therapy for Patients with Infradiaphragmatic Lymphoma, International Journal of Radiation Oncology*Biology*Physics, Volume 117, Issue 2, Supplement, 2023, Page e470, ISSN 0360-3016, https://doi.org/10.1016/j.ijrobp.2023.06.1676.
Hotsinpiller WS, Clark AR, et al. Trends and Predictors of Proton Therapy Utilization in Early-Stage Hodgkin Lymphoma: A National Cancer Database Analysis. Int J Radiat Oncol Biol Phys. 2784| Volume 114, ISSUE 3, Supplement, E351, November 01, 2022. DOI: https://doi.org/10.1016/j.ijrobp.2022.07.1458
Bates JE, Terezakis S, et al. Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma. Int J Part Ther (2021). doi.org/10.14338/IJPT-21-00011.1
Konig L, Haering P, et. al. Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Front Oncol. 2020 Jul 7.
Ntentas G, Dedeckova K, et. al. Clinical intensity-modulated proton therapy for Hodgkin lymphoma: which patients benefit the most? Pract Radiat Oncol. 2019 Jan 29. pii: S1879-8500(19)30007-4.
Zeng C, Plastaras J, et. al. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment Acta Oncologica 2016; 55 (9-10).
Scorsetti M, Cozzi L, et, al. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin’s lymphoma. Assessment of risk of toxicity and secondary cancer induction. Radiat Oncol, 2020 Jan 13.
Ashlyn S Everett, Bardford S Hoppe, Debbie Louis. et. al. Comparison of Techniques for Involved-Site Radiation Therapy in Patients with Lower Mediastinal Lymphoma. Pract Radiat Oncol. 2019 Oct May 22.
Jacob Eckstein, Isabelle Choi , et al. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results from a Multi-Institutional Prospective Registry. Advances in Radiation Oncology, 2023, 101250, ISSN 2452-1094, https://doi.org/10.1016/j.adro.2023.101250.
Raturi V, Hojo H, et. al. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head. Radiat Oncol. 2020 June 22.
Rutenberg M, Nichols R, et. al. Proton beam radiotherapy for pancreas cancer. J Gastrointest Oncol. 2020 Feb; 11(1): 166–175.
Jethwa K, Tryggestad E, et. al. Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes. Advances in Radiation Oncology. 2018;3(3):314-321.
Blommaert J, De Saint-Hubert M, Depuydt T, et al. Challenges and opportunities for proton therapy during pregnancy. Acta Obstet Gynecol Scand. 2024; 103: 767-774. doi:10.1111/aogs.14645
Vennarini S, Colombo F, et al. Proton therapy for pediatric malignancies: Indications and challenges focusing on the oncological landscape. Tumori Journal. 2024;110(6):416-421. doi:10.1177/03008916241287016
Gill, GS, Allison AW, et al. Long Term Proton Therapy Outcomes in the Reirradiation Setting for Recurrent Pediatric Ependymoma. International Journal of Radiation Oncology, Biology, Physics, Volume 120, Issue 2, e687. 2024; DOI: 10.1016/j.ijrobp.2024.07.1509
C.E. Hill-Kayser, Y. Li, et al. Survival and Local Recurrence Risk in Patients with High-Risk Neuroblastoma Treated with Proton Therapy over a 10 Year Interval, International Journal of Radiation Oncology*Biology*Physics, Volume 117, Issue 2, Supplement, 2023, Pages e516-e517, ISSN 0360-3016, https://doi.org/10.1016/j.ijrobp.2023.06.1780.
D. Leiser, T. Dantonello, R. Krcek, et al. Long Term Clinical Outcome and Quality of Life of Children, Adolescents and Young Adults Treated with Pencil Beam Scanning Proton Therapy for Rhabdomyosarcoma, International Journal of Radiation Oncology*Biology*Physics, Volume 117, Issue 2, Supplement, 2023, Page S77, ISSN 0360-3016, https://doi.org/10.1016/j.ijrobp.2023.06.391.
J. Sienna, L. Kahalley, et al. Dose Reductions to Critical Brain Organs-at-Risk and Better Cognition in Children with Medulloblastoma Receiving Proton Therapy, International Journal of Radiation Oncology*Biology*Physics, Volume 117, Issue 2, Supplement, 2023, Page S134, ISSN 0360-3016, https://doi.org/10.1016/j.ijrobp.2023.06.536.
Berlin E, Eisenberg R, Hill-Kayser C, et al. Delivery of Re-irradiation and Complex Palliative Radiotherapy Using Proton Therapy in Pediatric Cancer Patients. Authorea Preprints; 2023. DOI: 10.22541/au.168301665.52443287/v1.
Grippin AJ, McGovern SL. Proton therapy for pediatric diencephalic tumors. Front Oncol. 2023;13:1123082. Published 2023 May 5. doi:10.3389/fonc.2023.1123082
Myrsini Ioakeim-Ioannidou, Andrzej Niemierko, et al. Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients, Neuro-Oncology, 2023;, noad068, https://doi.org/10.1093/neuonc/noad068
Fortune IV EC, Indelicato DJ, et al. Outcomes Following Proton Radiotherapy for Pediatric Salivary Gland Tumors. Int J Radiat Oncol Biol Phys. 3068| Volume 114, ISSUE 3, Supplement, E479, November 01, 2022. DOI:https://doi.org/10.1016/j.ijrobp.2022.07.1743
VEMBER 01, 2022
Hill-Kayser CE, Vogel J, et al. Conformal Pencil Beam Scanning Proton Therapy for Delivery of Flank Radiation in Children with Renal Tumors. Int J Radiat Oncol Biol Phys. 228| Volume 114, ISSUE 3, Supplement, S71-S72, November 01, 2022. DOI: https://doi.org/10.1016/j.ijrobp.2022.07.466
M.J. LaRiviere, James P, et al. Pencil Beam Scanning (PBS) Proton Therapy for Children Requiring Radiotherapy with Anesthesia (GA) for Pelvic Rhabdomyosarcoma (RMS). Int J Radiat Oncol Biol Phys. 3090| Volume 114, ISSUE 3, Supplement, E489-E490, November 01, 2022. DOI: https://doi.org/10.1016/j.ijrobp.2022.07.1765
Upadhyay R, Yadav D, Venkatesulu BP, et al. Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis. Front Oncol. 2022;12:893855. Published 2022 Aug 12. doi:10.3389/fonc.2022.893855
Ruggi A, Melchionda F, Sardi I, et al. Toxicity and Clinical Results after Proton Therapy for Pediatric Medulloblastoma: A Multi-Centric Retrospective Study. Cancers (Basel). 2022;14(11):2747. Published 2022 Jun 1. doi:10.3390/cancers14112747
Bachmann N, Vazquez M, Bolsi A, et al. RONC-02. Clinical outcome after craniospinal irradiation with pencil beam scanning proton therapy for children and young adults/adolescents with brain tumors. Neuro Oncol.2022;24(Suppl 1):i176. Published 2022 Jun 3. doi:10.1093/neuonc/noac079.656
Vennarini, S., Del Baldo, G, et, al. Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors. Cancers 2022, 14, 1653. https://doi.org/10.3390/cancers14071653
Christopher R. Weil, MD, Felicia H. Lew, DVM, et, al. Patterns of Care and Utilization Disparities in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Radiat Oncol. Feb 15, 2022. Doi: https://doi.org/10.1016/j.adro.2021.100868
Udalov YuD, Slobina EL, et, al. Proton Therapy For Re-Irradiation of Pediatric Diffuse Brain Stem Tumors.Extreme Medicine. 2021 Jul. Doi: 10.47183/mes.2021.039
S Peters, Majer M, Ambrožová l, et al. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT and scanning proton radiotherapy – a phantom study. Med. Phys.. (2022), Accepted Author Manuscript. https://doi.org/10.1002/mp.15493
Tringale RK, Modin AL, et al. Vital organ sparing with proton therapy for pediatric hodgkin lymphoma: Toxicity and outcomes in 50 patients. Radiother Oncol. Jan 27, 2022.
DOI:https://doi.org/10.1016/j.radonc.2022.01.016
S Peters, J Merta, L Schmidt, et al. Evaluation of dose, volume and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study. Neuro-Oncology, 2021; noab301, https://doi.org/10.1093/neuonc/noab301
Cunningham D, Zaniletti I, et, al. Lymphopenia in Pediatric Patients Following Proton Radiotherapy. Int J Radiat Oncol Biol Phys. Volume 111, Issue 3, Supplement, 1 November 2021, Page e173.doi: https://doi.org/10.1016/j.ijrobp.2021.07.658
Upadhyay R, Grosshans D.R, et,al. Quantifying the Risk and Dosimetric Variables of Symptomatic Brainstem Injury After Proton Beam Radiation in Pediatric Brain Tumors. Int J Radiat Oncol Biol Phys. Volume 111, Issue 3, Supplement, 1 November 2021, Pages S82-S83. doi: https://doi.org/10.1016/j.ijrobp.2021.07.198
Indelicato DJ, Ioakeim-Ioannidou M, et, al. Bicentric Treatment Outcomes following Proton Therapy for Non-Myxopapillary High-Grade Spinal Cord Ependymoma in Children. Int J Radiat Oncol Biol Phys. September 28,2021. doi: https://doi.org/10.1016/j.ijrobp.2021.09.030
R Suzuki, H Fukushinma., et.al. Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma. Rep Pract Oncol Radiother. 2021 Aug 12;26(4):616-625.
Eaton B.R., Fong G.W., et al. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma. Cancer. 13 July 2021. doi.org/10.1002/cncr.33774
Taylor S, Lim P, et al. Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in pediatric abdominal neuroblastoma. Phys Imaging Radiat Oncol. 2021 Jul 9; 19: 45-52. doi: 10.1016/j.phro.2021.06.003.
Biewald E., Kiefer., et.al. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers (Basel). 2021 Apr; 13(8): 1862. doi: 10.3390/cancers13081862.
Rombi B, Ruggi A, et al. Proton therapy: A therapeutic opportunity for aggressive pediatric meningioma.Pediatric Blood& Cancer, 07 March 2021.
Gallagher KJ, Youssef B, et. al. Proton Radiotherapy Could Reduce the Risk of Fatal Second Cancers for Children with Intracranial Tumors in Low- and Middle-Income Countries. Int J Part Ther (2021).
Looi WS, Indelicato DJ, Mailhot Vega RB, Morris CG, Sandler E, Aldana PR, Bradley JA. Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma. Pediatr Blood Cancer. 2020 Nov 23: e28820. doi: 10.1002/pbc.28820. Epub ahead of print. PMID: 33226179.
Sahaja A, Huang C, et, al. Adaptive Proton Therapy for Pediatric Patients: Improving the Quality of the Delivered Plan With On-Treatment MRI. International Journal of Radiation Oncology, Biology, Physics, October 28, 2020
Sahaja A, Huang C, et, al. Adaptive Proton Therapy for Pediatric Patients: Improving the Quality of the Delivered Plan With On-Treatment MRI. International Journal of Radiation Oncology, Biology, Physics, October 28, 2020
Yazdi H, Meadows R. Child Proton Beam Therapy: a qualitative study of parental views on treatment and information sources. Surrey Research Insight, 2020.
Boilk N, Hall M, et. al. Psychosocial Support for Pediatric Patients at Proton Therapy Institutions. Int J Part Ther, 2020
Uezono H, Indelicato D, et. al. Treatment Outcomes Following Proton Therapy for Ewing Sarcoma of the Pelvis. Radiation Oncol. 2020 May 10.
Greenberger BA, Yock TI. The role of proton therapy in pediatric malignancies: Recent advances and future directions. Semin Oncol. 2020 Feb 21. pii: S0093-7754(20)30002-6.
Greenberger BA, Yock TI. The role of proton therapy in pediatric malignancies: Recent advances and future directions. Semin Oncol. 2020 Feb 21. pii: S0093-7754(20)30002-6.
Indelicato D, Rotondo R, et. al. Outcomes following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.Int J Radiat Oncol Biol Phys. 2020 Jan 24.
Sardaro A, Carbonara R, Petruzzelli M, et. al. Proton therapy in the most common pediatric non-central nervous system malignancies: an overview of clinical and dosimetric outcomes. Ital J Pediatr. 2019 Dec 27; 45:170.
R. Frakulli, S. Nagaraja, T. Steinmeier, et. al. Early ototoxicity in children after craniospinal irradiation using pencil beam proton therapy. Int J Radiat Oncol Biol Phys. 2019 Nov 15; 105 (4): E912.
S.M. Kharod, D.J. Indelicato, R.L. Rotondo, et, al. Outcomes Following Proton Therapy for Ewing Sarcoma of the Cranium and Skull Base. Int J Radiat Oncol Biol Phys. 2019 Sep 1; 105 (1): E635
M. Ioakeim-Ioannidou, K.X. Liu, et, al. A Multi-Institutional Retrospective Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Medulloblastoma Patients. Int J Radiat Oncol Biol Phys. 2019 Sep 1; 105 (1): E625-E626
Hashimoto T, Shimizu S, et. al. Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults. J Radiation Res. 2019 May 21; pii: rrz022.
Sakthivel V, Ganesh KM, et. al. Second malignant neoplasm risk after craniospinal irradiation in X-ray-based techniques compared to proton therapy. Australas Phys Eng Sci Med. 2019 Feb 6.
Hill-Kayser CE, Tochner Z, et. al. Outcomes after Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma . Int J Radiat Oncol Biol Phys. 2019 Feb 7. pii: S0360-3016(19)30190-7.
Journy N, Indelicato D, Withrow D, et. al. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiotherapy and Oncology. 2018. In Press.
Huynh M, Marcu LG, Giles E, et. al. Current status of proton therapy outcome for paediatric cancers of the central nervous system - Analysis of the published literature. Cancer Treat Rev. 2018 Nov;70:272-288.
Ladra MM, MacDonald SM, Terezakis SA. Proton therapy for central nervous system tumors in children. Pediatr Blood Cancer. 2018 Jul;65(7):e27046.
Pulsifer MB, Duncanson H, Grieco J, et al. Cognitive and Adaptive Outcomes Following Proton Radiation for Pediatric Patients with Brain Tumors. Int J Radiat Oncol Biol Phys. 2018.
Haas-Kogan D, Indelicato D, Paganetti H, et. al. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):152-168.
Bojaxhiu B, Ahlhelm F, Walser M, et. al. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy. Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):987-996.
K.R. Gergelis, M. Bai, et al. Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy and Intensity-Modulated Proton Therapy for Localized Prostate Cancer.International Journal of Radiation Oncology*Biology*Physics, Volume 117, Issue 2, Supplement, 2023, Page e385, ISSN 0360-3016, https://doi.org/10.1016/j.ijrobp.2023.06.2502.
Sosa AJ, Thames HD, Sanders JW, et al. Proton Therapy for the Management of Localized Prostate Cancer: Long-Term Clinical Outcomes at a Comprehensive Cancer Center .Published online ahead of print, 2023 Aug 17. Radiother Oncol. 2023;109854. doi:10.1016/j.radonc.2023.109854
Mariluz De Ornelas, Giuseppe Carlo Iorio, et al. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy – A proton versus photon comparison. Physica Medica, Volume 112, 2023, 102644, ISSN 1120-1797. doi.org/10.1016/j.ejmp.2023.102644.
Goginen Ei, Cruickshank L, et al. In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer. Acta Oncol. 2023 Jun 22;1-6. doi: 10.1080/0284186X.2023.2224925
Schmid MP, Harrabi S, Herfarth K, et al. Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes. Cancers (Basel). 2022;14(24):6045. Published 2022 Dec 8. doi:10.3390/cancers14246045
Sosa AJ, Choi S, et al. Proton Therapy for Localized Prostate Cancer: Long-Term Clinical Outcomes at a Comprehensive Cancer Center. Int J Radiat Oncol Biol Phys. 2552| Volume 114, ISSUE 3, Supplement, E247-E248, November 01, 2022. DOI: https://doi.org/10.1016/j.ijrobp.2022.07.1224
Chilukuri S, Sundar S, Patro K, et al. Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation. Int J Part Ther. 2022;9(1):42-53. Published 2022 Jun 13. doi:10.14338/IJPT-21-00042.1
Yoshimura T, Nishioka K, et, al. A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. Volume 20, October 2021, Pages 23-29. doi: https://doi.org/10.1016/j.phro.2021.09.006
Dutz A, Agolli L, et. al. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis. Acta Oncol. 2019 Mar 18:1-10.
Wang CJ, Guarisco. Prospective Safety and Patient-Reported Quality-of-Life Outcome for Prostate Cancer Treated with Image-Guided Compact Pencil-Beam Proton Unit. Int J Radiat Oncol Biol Phys. 2018 Nov. 102(suppl 3): e148.
Ong A, Ang, KW, et. al. Intensity-modulated radiotherapy for whole pelvis irradiation in prostate cancer: A dosimetric and plan robustness study between photons and protons. Technical Innovations & Patient Support in Radiation Oncology. 2018;6:11-19.
Lee H, Macomber M, et. al. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. Radiation Oncology. 2018;13(1):1-9.
M.Fok, S. Toh, J.E. Maducolil, et al. 455 Proton Beam Therapy in Rectal Cancer: A Systematic Review and Meta-Analysis. British Journal of Surgery, Volume 108, Issue Supplement_2, May 2021, znab135.020, https://doi.org/10.1093/bjs/znab135.020
Koroulakis A, Molitoris J, Kaiser A, et, al. RE-IRRADIATION FOR RECTAL CANCER USING PENCIL-BEAM SCANNING PROTON THERAPY: A SINGLE INSTITUTIONAL EXPERIENCE, Advances in Radiation Oncology. 2020 Oct 14.
Vaios E, Wo J, et. al. Proton beam radiotherapy for anal and rectal cancers. J Gastrointest Oncol. 2020 Feb; 11(1): 176–186.
Wang Y, Deng W, Li N, et al. Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions. Front Pharmacol. 2018;9:185.
Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer 2018; 9(10):1773-1781.
Lee HJ, Zeng J, Rengan R. Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer. Transl Lung Cancer Res. 2018;7(2):180-188.
Nakajima K, Sudo S, et al. Image-Guided Proton Therapy for Unresectable Trunk Soft-Tissue Sarcoma. International Journal of Radiation Oncology, Biology, Physics, Volume 120, Issue 2, e474 - e475. 2024; DOI: 10.1016/j.ijrobp.2024.07.1055
Moon SH, Suh Y. The Role of Modern Radiotherapy Technology in the Treatment of Esophageal Cancer.Korean J Thorac Cardiovasc Surg. 2020 Aug 5; 53(4): 184 -190.
Jethwa KR, Haddock MG, et, al. The emerging role of proton therapy for esophagus cancer. J Gastrointest Oncol. 2020 Feb;11(1):144-156.
Lin SH, Hobbs BP, Verma V, et, al. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol. 2020 Mar 11: JCO1902503.
DeCesaris CM, McCarroll R, Mishra MV, et. al. Assessing Outcomes of Patients Treated with Re-irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction. J Thorac Oncol. 2020 Mar 4. pii: S1556-0864(20)30144-1.
Celik E, Baus W, et. al. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer. Radiation Oncol. 2020 May 24.
Patel S, Edgington S. et. al. Novel use of proton beam therapy for neoadjuvant treatment of radiation-associated squamous cell carcinoma of the esophagus. J Gastrointest Cancer. 2019 Feb;10(1):155-160.
Beltran C, Schultz HL, et. al. Radiation biology considerations of proton therapy for gastrointestinal cancers. J Gastrointest Oncol. 2020 Feb; 11(1):225-230.
Barsky AR, Reddy VK, Plastaras JP, et. al. Proton beam re-irradiation for gastrointestinal malignancies: a systematic review. J Gastrointest Oncol. 2020 Feb; 11(1):187-202.
Liu C, Bhangoo RS, et. al. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies. J Appl Clin Med Phys. 2019 May 21; 257(6):1309-1318.
FUKUMITSU N, ISHIKAWA H, et, al. Proton Therapy for Primary Renal Cell Carcinoma: The First Nationwide Retrospective Study in Japan. International Journal of Experimental and Clinical Pathophysiology and Drug Research. 2020 Jun 29.
Bush, DA, Volk, M., Smith, JC, et al. Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial. Cancer. 2023; 1-10. doi:10.1002/cncr.34965
Chen MF, Chen PT, Hsieh CC, Wang CC. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma. Cells. 2023;12(2):332. Published 2023 Jan 15. doi:10.3390/cells12020332
Kim TH, Kim BH, Park JW, et al. Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade. Cancers (Basel). 2022;14(18):4445. Published 2022 Sep 13. doi:10.3390/cancers14184445
Dionisi F, Scartoni D, Fracchiolla F, et al. Proton therapy in the treatment of hepatocellular carcinoma. Front Oncol. 2022;12:959552. Published 2022 Aug 8. doi:10.3389/fonc.2022.959552
R.S. Bhangoo, T.C. Mullikin., et.al. Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience. Adv Radiat Oncol. 2021 Mar 2;6(4):100675. Doi: 10.1016/j.adro.2021.100675.
M Moteabbed, J Smeets., et.al. Toward MR-integrated proton therapy: modeling the potential benefits for liver tumors. Phys Med Biol. 2021 Aug 18. Doi: 10.1088/1361-6560/ac1ef2.
Iwata H, Ogino H, et.al. Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation. Cancers (Basel). 2021 Jan; 13(2): 219. doi: 10.3390/cancers13020219
Chuong M, Kaiser A, Molitoris J, et. al. Proton beam therapy for liver cancers. J Gastrointest Oncol. 2020 Feb; 11(1): 157–165.
Shaakir Hasan, Stephen Abel, Vivek Verma. et. al. Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation. J Gastrointest Oncol. 2019 Oct; 10(5): 999-1009.
Patel JS, McCall NS, et al. Immune System Dose With Proton Versus Photon Radiotherapy for Treatment of Locally Advanced NSCLC. International Journal of Particle Therapy, Volume 12, 2024, 100016, ISSN 2331-5180, https://doi.org/10.1016/j.ijpt.2024.100016.
Iocolano M, Yegya-Raman N, Friedes C, et al. Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era. Cancer. 2024; 1-11. doi:10.1002/cncr.35230
Cortiula F, Hendriks L, et al. Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy. Radiotherapy and Oncology. Volume 190, 2024; 110019, ISSN 0167-8140, https://doi.org/10.1016/j.radonc.2023.110019.
Nakamura M, Ishikawa H, Ohnishi K, et al. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer, Journal of Radiation Research, 2023;, rrac084, https://doi.org/10.1093/jrr/rrac084
Suh YG, Noh JM, Lee DY, et al. Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer. Cancers (Basel). 2022;14(15):3627. Published 2022 Jul 26. doi:10.3390/cancers14153627
Oonsiri S, Kitpanit S, et al. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer. Phys Imaging Radiat Oncol. 2022;22:51-56. Published 2022 Apr 28. doi:10.1016/j.phro.2022.04.005
König L, Hörner-Rieber J, et al. Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers (Basel). 2022;14(10):2409. Published 2022 May 13. doi:10.3390/cancers14102409
Noh, J.M., Yoo, H, et, al. Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis. Cancers 2022, 14, 1445. https://doi.org/10.3390/cancers14061445
Mohindra P, Saeed A, et, al. Toxicity and Survival Outcomes From Intensity Modulated Proton Therapy-Based Re-Irradiation in Patients With Non-Small Cell Lung Cancer. International Journal of Radiation Oncology • Biology • Physics. Volume 112, Issue 2, E4-E5. Feb 01, 2022. Doi:I:https://doi.org/10.1016/j.ijrobp.2021.10.167
Bayasgalan U, Moon SH, et al. Dosimetric Comparisons between Proton Beam Therapy and Modern Photon Radiation Techniques for Stage I Non-Small Cell Lung Cancer According to Tumor Location. Cancers (Basel). 2021;13(24):6356. Published 2021 Dec 17. doi:10.3390/cancers13246356
Köthe A, Bizzocchi A, et,al. Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer. Radiat Oncol. 2021; 16: 199. Published online 2021 Oct 11. doi: 10.1186/s13014-021-01914-2
Kim N, Noh JM, Lee W, Park B, Pyo H. Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis. Cancers. 2021; 13(14):3497. https://doi.org/10.3390/cancers13143497.
Nagata I, Ogino T, et, al. Clinical Outcomes of Proton Beam Therapy for Ground-Glass Opacity-Type Lung Cancer. Lung Cancer (Auckl). 2020; 11:105-111
P. Mohindra,S. Mossahebi, J.M. Moreau, et, al. First Clinical Experience of Gated Voluntary Breath-Hold Intensity Modulated Proton Therapy for Thoracic Malignancies. Int J Radiat Oncol Biol Phys. 2019 Sep 1; 105 (1): S252
Rice SR, Saboury B, et. al. Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy. Nucl Med Commun. 2019 Jun;40(6):618-625.
Chen J, Lu JL, et. al. Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy. Radiat Oncol. 2019 Jan 25;14:16.
Kim H, Pyo H, Noh JM, et. al. Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.Radiat Oncol. 2019 Jan 28;14(1):19.
Liu C, Sio TT, et. al. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study. J Appl Clin Med Phys. 2018 Oct 17.
Huang Q, Jabbour SK, Xiao Z, et. al. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer. Radiat Oncol. 2018 Apr 25;13(1):78.
Lee E, Zeng J, Miyaoka RS, et. al. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy. Med Phys. 2017 Jul;44(7):3418-3429.
Ho JC, Nguyen QN, Li H, et. al. Reirradiation of thoracic cancers with intensity modulated proton therapy. Pract Radiat Oncol. 2018 Jan - Feb;8(1):58-65.
Daniel R. Gomez, Andreas Rimner, et.al. The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Re ReJ Thorac Oncol, 2019 Jul; 14(7):1172-1183.
